La TEP en gynéco-oncologie,au-delà du [18F]FDG ?

Understanding the mechanisms of carcinogenesis led to the development of new therapeutic approaches over the last decades, according to the specificities of tumor phenotypes, particularly in gynecological malignancies. 18F]FDG PET does not specifically assess these potential therapeutic targets. This update details the innovative PET tracers studied for this purpose, according to three families of oncological characteristics: tumor receptors, oncological mechanisms and tumor microenvironment.